Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease
- PMID: 16600437
- DOI: 10.1016/j.neurobiolaging.2006.02.013
Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease
Abstract
It is unclear how circulating T cells cross the blood-brain barrier (BBB) and participate in the inflammation process in Alzheimer's disease (AD). Here we showed significantly higher macrophage inflammatory protein-1alpha (MIP-1alpha) expression in peripheral T lymphocytes of AD patients than age-matched controls. T cells crossing of the human brain microvascular endothelial cells (HBMECs) which constitute the BBB, were almost completely abrogated by anti-MIP-1alpha antibody. MIP-1alpha induced the expression of CCR5, a potential MIP-1alpha receptor, on HBMECs. HBMECs tranfected with CCR5 resulted in increased T cells transendothelial migration. CCR5 antagonist (2D7 mAb) blocked the T cells transmigration. The MIP-1alpha-CCR5 interaction promoted T cells transendothelial migration via ROCK (Rho kinase). Furthermore, Abeta injection into rats' hippocampus induced MIP-1alpha overexpression accompanied with increased T lymphocytes occurrence in the brain cortex and this enhanced T cells entry was effectively blocked by anti-MIP-1alpha antibody. These data are the first to suggest that the interaction between MIP-1alpha overexpressed by T cells and CCR5 on HBMECs is involved in AD patients' T cells migrating from blood to brain.
Similar articles
-
Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.J Immunol. 2009 May 1;182(9):5778-88. doi: 10.4049/jimmunol.0803013. J Immunol. 2009. PMID: 19380826
-
Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.J Infect Dis. 2002 Jun 15;185(12):1803-7. doi: 10.1086/340829. Epub 2002 May 20. J Infect Dis. 2002. PMID: 12085329
-
A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.Cancer Res. 2002 Jul 1;62(13):3751-8. Cancer Res. 2002. PMID: 12097285
-
The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.J Viral Hepat. 2007 Oct;14(10):675-87. doi: 10.1111/j.1365-2893.2006.00838.x. J Viral Hepat. 2007. PMID: 17875002 Review.
-
Cerebrovascular gene linked to Alzheimer's disease pathology.Trends Mol Med. 2005 Dec;11(12):534-6. doi: 10.1016/j.molmed.2005.10.008. Epub 2005 Nov 8. Trends Mol Med. 2005. PMID: 16288900 Review.
Cited by
-
Glutamate‑mediated effects of caffeine and interferon‑γ on mercury-induced toxicity.Int J Mol Med. 2017 May;39(5):1215-1223. doi: 10.3892/ijmm.2017.2937. Epub 2017 Mar 27. Int J Mol Med. 2017. PMID: 28350110 Free PMC article.
-
Acquired immunity and Alzheimer's disease.J Biomed Res. 2022 Jul 28;37(1):15-29. doi: 10.7555/JBR.36.20220083. J Biomed Res. 2022. PMID: 36165328 Free PMC article.
-
The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer's disease.Neural Regen Res. 2022 Nov;17(11):2355-2363. doi: 10.4103/1673-5374.335829. Neural Regen Res. 2022. PMID: 35535871 Free PMC article. Review.
-
Altered peripheral profile of blood cells in Alzheimer disease: A hospital-based case-control study.Medicine (Baltimore). 2017 May;96(21):e6843. doi: 10.1097/MD.0000000000006843. Medicine (Baltimore). 2017. PMID: 28538375 Free PMC article.
-
Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness.Oncotarget. 2016 Aug 16;7(33):53797-53807. doi: 10.18632/oncotarget.10777. Oncotarget. 2016. PMID: 27462773 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
